Proscia

A surgeon operating while other clinicians follow along on a laptop using Proximie's platform
By  Emily Olsen 01:10 pm June 14, 2022
Pharmacy benefit manager Capital Rx raised $106 million in a Series C funding round led by B Capital. The round included participation from General Catalyst and existing investors Transformation Capital and Edison Partners. Capital Rx said its total funding pot now totals $175 million. The company offers the JUDI platform, pharmacy benefits software that includes tools for building and...
By  MobiHealthNews 02:25 pm March 15, 2021
IMA Clinical Research, a division of the IMA Group that provides clinical evaluation and research services, has partnered with AiCure to deploy the patient engagement company's Patient Connect tool to patients in a new effort to observe health management beyond the traditional study setting. The 30-day program will have participants using the smartphone app to confirm adherent dosing behavior and...
By  Laura Lovett 02:36 pm December 1, 2020
Digital pathology startup Proscia landed $23 million in Series B funding. The latest round was led by Scale Venture Partners with participation from Hitachi Ventures.  This comes roughly two years after the company closed its $8.5 million Series A round of funding.  WHAT THEY DO  The company’s main software platform is called Concentriq, which focuses on computational pathology. The tech uses...
By  MobiHealthNews 03:55 pm March 3, 2020
Fitbit and Belgium-based FibriCheck have extended their partnership to bring the latter’s atrial fibrillation detection app to four new countries in the EU: France, Germany, Italy and Spain. It was previously made available to Fitbit smartwatch users in the UK, Ireland, the Netherlands and Belgium back in September 2019. “For more than a decade, Fitbit has helped millions of people around the...
By  Laura Lovett 03:50 pm September 26, 2018
What happened This morning digital pathology startup Proscia announced that it closed a $8.3 million Series A funding round. The financing was led by Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures and RobinHood Ventures.  The impact The Philadelphia-base startup plans to use the new money to commercialize its digital pathology...